Variant position: 2311 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 4967 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NPVEGERYLDFLRFAVFCNG ESVEENANVVVRLLIRRPECF
Mouse NPVEGERYLDFLRFAVFCNG ESVEENANVVVRLLIRRPECF
Rat NPVEGERYLDFLRFAVFCNG ESVEENANVVVRLLIRRPECF
Rabbit NPVEGERYLDFLRFAVFCNG ESVEENANVVVRLLIRRPECF
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 4967 Ryanodine receptor 2
1 – 4281 Cytoplasmic
853 – 2925 4 X approximate repeats
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Priori S.G.; Napolitano C.; Memmi M.; Colombi B.; Drago F.; Gasparini M.; DeSimone L.; Coltorti F.; Bloise R.; Keegan R.; Cruz Filho F.E.S.; Vignati G.; Benatar A.; DeLogu A.;
Cited for: VARIANTS CPVT1 LEU-2246; ASP-2311; SER-2474; PHE-3778; SER-3946; SER-3946; LYS-4104; CYS-4497; ILE-4771; GLY-4860; MET-4867; ASP-4895 AND LYS-4950;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.